PSMA—targeted NIR dyes and their uses
US10456482B2 · kind B2 · utility
10Cited by
3References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2017 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Sep 6, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/948
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to prostate specific membrane antigen (PSMA) targeted compounds conjugated to near-infra red (NIR) dyes and methods for their therapeutic and diagnostic use. More specifically, this disclosure provides compounds and methods for diagnosing and treating diseases associated with cells and/or vasculature expressing prostate specific membrane antigen (PSMA), such as prostate cancer and related diseases. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.